Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
254 studies found for:    BLM
Show Display Options
Rank Status Study
1 Completed Dose Escalating Study for Amphinex-based PCI of Bleomycin.
Condition: Cutaneous or Sub-cutaneous Malignancies
Interventions: Drug: Amphinex;   Drug: Bleomycin;   Device: Laser
2 Completed Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Device: Medpulser Electroporation with Bleomycin
3 Not yet recruiting Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD
Condition: Acute GVH Disease
Interventions: Drug: Recombinant Human Interleukin-22 IgG2-Fc (F-652);   Drug: Systemic Corticosteroids
4 Completed Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane)
Condition: Anesthesia
Interventions: Drug: desflurane;   Drug: desflurane/nitrous oxide;   Drug: sevoflurane/nitrous oxide
5 Recruiting Use of F-652 in Patients With Alcoholic Hepatitis
Condition: Alcoholic Hepatitis
Intervention: Drug: F-652
6 Completed Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Intervention: Biological: bleomycin sulfate
7 Completed Biological Significance of the Bloom's Syndrome Protein
Condition: Bloom Syndrome
Intervention:
8 Suspended Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Cancer
Interventions: Device: Medpulser Electroporation with Bleomycin;   Procedure: Surgical Excision
9 Completed Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer
Condition: Cancer
Intervention: Device: MedPulser Electroporation with bleomycin
10 Completed A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the Knee
Condition: Osteoarthritis of the Knee
Interventions: Drug: ABT-652 NSAID;   Drug: Placebo NSAID
11 Suspended Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Cancer
Interventions: Device: Medpulser electroporation with Bleomycin;   Procedure: Tumor surgical excision
12 Terminated
Has Results
Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: bleomycin;   Device: Ommaya reservoir;   Radiation: radiation therapy
13 Not yet recruiting Electrosclerotherapy for Capillary Malformations
Conditions: Capillary Malformations;   Vascular Malformations
Interventions: Other: Electrosclerotherapy;   Drug: Intralesional bleomycin injection
14 Completed A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients
Condition: HIV-1 Infection
Interventions: Drug: TBR-652;   Drug: TBR-652 Matching Placebo;   Drug: TBR-652 50 mg;   Drug: TBR-652 75 mg;   Drug: TBR-652 100 mg;   Drug: TBR-652 150 mg
15 Completed A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee
Condition: Osteoarthritis of the Knee
Interventions: Drug: ABT-652;   Drug: Placebo;   Drug: Naproxen
16 Completed
Has Results
Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease
Condition: Lymphoma
Interventions: Drug: Interferon-2A;   Drug: Adriamycin;   Drug: Bleomycin;   Drug: Velban;   Drug: Dacarbazine
17 Terminated A Study to Evaluate the Safety and Efficacy of PC-A11 in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
Conditions: Recurrent Head and Neck Cancer;   Carcinoma, Squamous Cell of Head and Neck
Intervention: Drug: Amphinex induced PCI of bleomycin
18 Unknown  Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations
Condition: Venous Malformation
Interventions: Drug: Bleomycin;   Drug: Fibrovein;   Drug: Bleomycin + Fibrovein
19 Completed Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
Condition: Sleep Disorder
Interventions: Drug: ABT-652;   Drug: Placebo
20 Completed Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer
Conditions: Head and Neck Neoplasms;   Skin Neoplasms
Interventions: Drug: Amphinex (TPCS2a);   Drug: Bleomycin;   Other: Illumination with CeramOptec laser

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.